Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q1 2024 Q4 2023
Period Ending Mar 31, 2025 Mar 31, 2024 Dec 31, 2023
Net Income
-17.07M -6.88M -3.47M
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
436K 62K 31K
Other Working Capital
-738K -2.15M -1.31M
Other Non-Cash Items
1.07M 1.04M 105K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-531K -2.88M -801K
Operating Cash Flow
-16.1M -8.66M -4.14M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a n/a n/a
Debt Repayment
12.49M 4.99M n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
99.88M 112K 117K
Financial Cash Flow
120.7M 13.44M 6.86M
Net Cash Flow
104.61M 4.78M 2.72M
Free Cash Flow
-16.1M -8.66M -4.14M